WO1996001598A1 - Prosthetic devices - Google Patents
Prosthetic devices Download PDFInfo
- Publication number
- WO1996001598A1 WO1996001598A1 PCT/GB1995/001550 GB9501550W WO9601598A1 WO 1996001598 A1 WO1996001598 A1 WO 1996001598A1 GB 9501550 W GB9501550 W GB 9501550W WO 9601598 A1 WO9601598 A1 WO 9601598A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prosthesis
- reinforcing structure
- resiliently deformable
- deformable material
- cover
- Prior art date
Links
- 239000000463 material Substances 0.000 claims abstract description 27
- 239000000017 hydrogel Substances 0.000 claims abstract description 13
- 239000002131 composite material Substances 0.000 claims abstract description 8
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 5
- 230000003014 reinforcing effect Effects 0.000 claims description 17
- -1 knitted Substances 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 230000006835 compression Effects 0.000 claims description 3
- 238000007906 compression Methods 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 239000002759 woven fabric Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 1
- 239000004744 fabric Substances 0.000 description 13
- 239000000523 sample Substances 0.000 description 10
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010016654 Fibrosis Diseases 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000004761 fibrosis Effects 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- 229940095095 2-hydroxyethyl acrylate Drugs 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- BESKSSIEODQWBP-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C BESKSSIEODQWBP-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000070918 Cima Species 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- DRXQKPOLZQYYGG-UHFFFAOYSA-N [3-[bis(trimethylsilyloxy)silyloxy-bis(trimethylsilyloxy)silyl]-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound C(C(=C)C)(=O)OC(CCOC(C(=C)C)=O)[Si](O[SiH](O[Si](C)(C)C)O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C DRXQKPOLZQYYGG-UHFFFAOYSA-N 0.000 description 1
- XQBCVRSTVUHIGH-UHFFFAOYSA-L [dodecanoyloxy(dioctyl)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCCCCCC)(CCCCCCCC)OC(=O)CCCCCCCCCCC XQBCVRSTVUHIGH-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920001973 fluoroelastomer Polymers 0.000 description 1
- 229920005560 fluorosilicone rubber Polymers 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002684 laminectomy Methods 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 238000013031 physical testing Methods 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- LVLANIHJQRZTPY-UHFFFAOYSA-N vinyl carbamate Chemical compound NC(=O)OC=C LVLANIHJQRZTPY-UHFFFAOYSA-N 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30965—Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
Definitions
- the present invention relates to prosthetic devices and in particular to such devices which deform when in use (e.g. when under compressive load).
- One type of prosthesis is disclosed in US Patent No. 5047055 and comprises a hydrogel material in a shape which generally conforms to the intervertebral disc nucleus pulposes. When hydrated the hydrogel comprises a certain amount of free water which can leave the prosthesis when the disc is partially dehydrated or under mechanical pressure.
- intervertebral disc nucleus prosthesis comprises a multiplicity of hydrogel beads.
- the beads are covered by an external, semi-permeable membrane, which functions to retain the beads, but which permits fluids to flow in and out of the prosthetic nucleus.
- hydrogel materials employed in these prior devices have a tendency to become weaker and less able to withstand compressive loading as they become more fully hydrated. This may lead to failure of the prosthesis by fragmentation of the prosthesis material.
- the present invention seeks to reduce the risk of stress failure of said prostheses to reduce the risk of fragmentation which may lead to adverse reactions in a host.
- a prosthesis comprising a composite of a synthetic resiliently deformable material having at least partially embedded therein a physically discrete reinforcing structure.
- a further advantage of the prosthesis of the present invention is that it allows a wider range of resiliently deformable materials to be utilised than was hitherto the case. This is because the reinforcing structure can substantially contribute to the physical strength of the device, thereby allowing weaker deformable materials to be used than is the case with non reinforced prostheses.
- the prosthesis of the present invention is suitable for replacing body components which are subject to repeated and variable compressive loads and may be shaped so as to correspond to suitable body components.
- it may be used to replace the nucleus pulposus of the intervertebral disc, the intervertebral disc in its entirety, as a replacement for the articular cartilage in joints, in place of orthopaedic bearing surfaces (eg to replace polyethylene bearing surfaces), in total joint replacement implants such as the hip, knee, shoulder, wrist, ankle, fingers and toes, as a spacer to replace segments of bone or the bone in its entirety, as a space filling implant replacing soft tissue for orthopaedic, maxillo-facial, or plastic or reconstructive surgical applications - such as to replace or augment deficiencies in bone, cartilage or soft tissue.
- the prosthesis is adapted to replace part or all of an intervertebral disc of a mammal, e.g. a human, and is shaped accordingly.
- the prosthesis is adapted to replace an intervertebral disc nucleus and it therefore desirably has a shape generally corresponding to that of a natural disc nucleus.
- it may comprise a plurality of sections which are adapted, when fitted together to approximate the shape of the natural disc nucleus.
- the nucleus may be in two halves to allow easy manipulation and to facilitate minimally invasive surgical techniques.
- the reinforcing structure can be located partially or totally within the resiliently deformable material and is formed of a material which is physically discrete from said resiliently deformable material (although the reinforcing structure may itself be resiliently deformable). It is thus distinguished from systems in which polymers forming the resiliently deformable material are simply cross-linked.
- the material comprising the reinforcing structure may also be chemically distinct from that of the resilient material.
- the reinforcing structure may function by providing a restraining means within the deformable material which reduces the tendency of the latter to shear or otherwise fail when under compressive load.
- the resiliently deformable material is in solid or semi-solid form. It may be an elastomeric polymer. Preferably it is hydrogel or a hydrophilic polymer.
- Suitable hydrogels include PVA hydrogels, such as those disclosed in US-A-5192326.
- hydrogels or hydrophilic polymers include:
- Acrylates - eg acrylic acid, methacrylic acid, 2-hydroxyethyl methacrylate, and copolymers thereof with N-vinyl pyrrolidone, N- vinyl lactams, acylamide, polyurethanes, polyacrylonitrile; copolymers of N-vinyl pyrrolidone and glycidyl acrylate, copolymers of polyethylene, polytetrafluoroethylene or polypropylene with acrylic acid, block copolymers of poly (2-hydroxyethyl methacrylate) with polystyrene, or poly (dimethyl-siloxane), para-hydroxyperfluoro-alkyl styrene, or trifluoroethyl methacrylate;
- Acrylamides eg acrylamide, methacrylamide and copolymers of acrylamides such as poiyacrylamide-agarose gels, siloxy-acryiamides;
- Silicones - eg 1 ,3-bis-methacryloxy-propyl-1 ,1 ,3,3-tetrakis (trimethyl-siloxy) disiloxane, tris (trimethyl-siloxy) silyl-propyl methacrylate, siioxane monomers, polysiloxane-polyoxyalkylene macromers, silicone rubbers, hexamethyl disiloxane, triethoxyvinyl silane, hexamethyl disilazane;
- Collagen - eg copolymers with poly (2-hydroxyethyl-acrylate) or poly (vinyl alcohol);
- Vinyl compounds - eg N-vinyl pyrrolidone, N-vinyl lactams, hydroxyethyl cellulose vinyl and vinylic monomer, polymers of vinyl carbonate or vinyl carbamate, vinyl trifluro acetate;
- Polyurethanes - eg polyether, or short chain polyester based polyurethanes.
- Naturally occurring materials eg glucomannan gel, hyaluronic acid, proteins, poiysaccharides or polypeptides combined with a polymer of a hydrophilic acrylic or methacryiic acid derivative, crosslinked carboxyl containing polysaccharides, carboxymethyl cellulose, gelatin, aiginates.
- Preferred hydrogels have a water content of at least 30%
- elastomeric polymers which may be suitable for use in the present invention include:- silicone and fluorosilicone elastomers, phosphazene elastomers, vinylidine fluoride based fluoroelastomers, natural and artificial rubbers, etc.
- the prosthesis of the invention aptly has a compressive strength of at least 1 MNrrr 2 at 37°C and at atmospheric pressure.
- Suitable reinforcing structures include:- nets; foams; knitted, braided, crocheted, woven, or non-woven fabrics; arrays of spaced reinforcing elements; particulate filler materials; loose fibres.
- net includes perforate films as well as fibrous networks. Suitable nets include those formed of nylonTM, dacronTM, carbon fibre etc.
- the foams may be open cell foams, closed cell foams, skeletal foams, non-skeletal foams, etc.
- Foams which are already used in wound-dressings for example those polyurethane foams employed in wound dressings such as ALLEVYNTM foam, which is sold by Smith & Nephew Medical Ltd, Hull, UK may be particularly suitable.
- the fabrics used for reinforcing structures are aptly arranged as composite structures having desirably first and second spaced apart sheets whose opposed surfaces are maintained in a spaced apart relationship by a plurality of supporting members.
- the first and second spaced apart surfaces may be generally parallel to one another (when the fabric is not compressed). They may be generally planar or may present corrugated surfaces.
- Such fabrics are often formed by warp knitting using Raschel warp knitting machinery (as described eg in USPN 4601940 and EP-A-0529671). Certain type of fabrics of this are sometimes referred to as "spacer fabric” and have been used in seating in the automotive industry. Such fabrics can be obtained from Messrs. Nippon Mayer Co. Ltd. of J-910 Fukui City, Japan; M ⁇ ller Textile GmbH of D-51674 Wiehl- Drabenderh ⁇ he, Germany; or Karl Mayer Textilmaschienen fabrik of D-63160 Obertsha ⁇ sen, Germany.
- the surfaces of these composite structures may be maintained in the spaced apart relationship by, for example, columns of elastomeric material or by a plurality of fibrous members arranged, for example to form a web.
- Such webs may be formed from non-woven fabrics.
- the particulate filler material may employed is the reinforcing structure may be quartz, silica, gypsum, titanium dioxide, glass based fillers, clay-based fillers, or calcium carbonate. Filler materials are described in detail in the "Handbook of Fillers for Plastics" by Katz and Mikwski [1987], published by Van Nostrand Reinhold.
- the resiliently deformable material may be contained within an outer cover, which is desirably flexible.
- the outer cover is suitably non-permeable to body fluids.
- the outer cover may be provided to simply serve to assist in maintaining integrity or strength of the prosthesis.
- the outer cover may therefore be permeable to body fluids but prevent the resiliently deformable material and the reinforcing structure from passing through it.
- Aptly such outer covers will be in the form of a membrane or mesh.
- Various outer covers are disclosed in US-A- 5192326.
- This may take the form of a collar surrounding the prosthesis to constrain its lateral deflection.
- This collar may be of metal, polymeric, ceramic or composite construction and would surround the prosthesis circumferentially.
- This collar may be made of implantable metals such as stainless steel, cobalt chrome alloy, titanium alloy or ceramic materials such as alumina or zirconia, or composite materials such as carbon fibre reinforced PEEK, or polymers such as polyethylene.
- the prosthesis may be bonded to plates of metal, ceramic, polymer or composite construction which are interspersed between the prosthesis and the bone of the vertebral bodies in cephalad and caudad directions to facilitate anchorage to the bone.
- the prosthesis of the present invention is necessary to introduce it into a host. This can be done by any appropriate surgical technique, but minimally invasive techniques are preferred where possible.
- a prosthesis consisting of an inter ⁇ vertebral disc nucleus prosthesis into the human body this may be done from the dorsal direction by dissecting away skin, soft tissue and muscle exposing the dorsal aspect of the spinal column.
- a laminectomy or other surgical procedure may be performed to remove the dorsal bony elements from the column to expose the disc.
- the disc nucleus prosthesis is then placed in position through a surgical defect created in the posterior surface of the annulus fibrosis.
- the spinal column may be approached from the dorsal-lateral direction without removing the dorsal bony elements, again introducing the disc nucleus prosthesis through a defect created surgically in the annulus fibrosis.
- an ventral approach to the spinal column may be used entering the body through the peritoneum or thorax to expose the ventral surface of the spinal column. The disc nucleus prosthesis would then be introduced through a defect created surgically in the anterior surface of the annulus fibrosis.
- the effected disc level would be distracted using standard surgical instruments to increase the height of the damaged disc to allow insertion of the disc nucleus prosthesis.
- Any of these surgical approaches may be made using a minimally invasive surgery technique such as arthroscopy, endoscopy or laparoscopy to approach the spinal column.
- the disc nucleus prosthesis would be introduced through a defect created surgically in the annulus fibrosis through a cannula using a percutaneous approach.
- the prosthesis may be dehydrated to reduce the volume of the prosthesis prior to insertion.
- the disc would then either be rehydrated in situ after implantation or be permitted to absorb water from the surrounding tissues during the post-operative period. This technique is particularly suitable for hydrogel prostheses.
- a complete intervertebral disc prosthesis could be introduced into the human body using any of the techniques described above, with the modification that the entire disc annulus fibrosis and nucleus pulposus or a substantial portion thereof would be removed using standard surgical procedures exposing the vertebral bones, cephalad and caudad to the disc space, and the prosthesis inserted to replace the entire disc.
- a prosthesis could be anchored using any of the means described previously.
- Metatin 812ES catalyst Trade Mark for a dioctyltin dilaurate catalyst obtainable from Cima Chemical Industries
- HPU 45 Hydrophilic polyurethane
- the cured HPU 45 was then broken into small pieces and dissolved by adding 15 parts by weight of tetrahydrofuran to 85 parts by weight of HPU 45.
- the resultant liquid was poured into shallow trays and left to evaporate solvent slowly in a fume cupboard over 19 hours.
- the samples were dried in an oven at 40°C for 4 hours then in a vacuum oven at 40°C for 3 hours.
- the resultant films were removed from the trays, turned over and the trays replaced in the vacuum oven for a final 5.5 hours.
- Equally sized discs of diameter 14mm and thickness 1mm were then cut out of the films. From a polyalkylene net obtainable from Smith & Nephew Extruded Films Ltd. of Gilberdyke, UK under the designation of "Net 909 (Grade L40)" further discs of diameter 14mm were cut. The thickness of these discs was 0.15mm and the nets weighed 13.6 g/m 2 .
- Sample A - Stack consists of two HPU 45 discs, then one net disc, then two HPU 45 discs, then one net disc, then two HPU 45 discs.
- Sample B (control) - Stack consists of six HPU 45 discs.
- the discs were laminated together by heating in an oven at 100°C for 10 mins with a 15g weight being placed on the top of each stack.
- the laminated stacks were allowed to cool to room temperature.
- Example 2 Synthesis of a poly Hydroxyethylmethacrylate hvdro ⁇ el reinforced with a knitted fabric.
- a stock solution was prepared by adding azoisobutylnitrile to hydroxyethylmethacrylate (HEMA) at a level of 0.15% w/w. The solution was then de-aerated by bubbling with nitrogen for 15 mins.
- HEMA hydroxyethylmethacrylate
- a mould was obtained for producing moulded discs shaped articles of diameter 14mm and depth 9mm.
- the solution was powered into the mould to a depth of about 2mm and a disc cut out of a knitted "spacer fabric" to have a diameter of 14mm was placed above the HEMA (once it had thickened sufficiently to support the disc).
- the knitted fabric was obtainable from under the designation of Karl Meyer Textelmaschinen Fabrik of D.63160 Obertshausen, Germany and consists of two planer surfaces interconnected by monofilaments. Each planar surface is knitted to provide a "honeycomb" structure of interconnecting hexagons. It has a thickness of about 5mm.
- the solution was then poured over the knitted fabric a until the mould was full and the mould was then sealed and put in a water bath (containing a tablespoon of sodium metabisulphite) at 50°C for 3 hours. The temperature was then increased to 80°C for 2 hours and then reduced to 60°C for 17 hours. The mould was finally put in an oven at 100°C for 24 hours to anneal.
- a water bath containing a tablespoon of sodium metabisulphite
- sample C After cooling at room temperature for several hours the mould was opened and the moulded article, referred to as sample C, was removed.
- sample D was also prepared, using a corresponding procedure to that described above except that no knitted fabric was used (ie sample D consisted of poly HEMA only).
- sample E was prepared, consisting of a sample of the knitted fabric only, cut to the same size as the moulded samples.
- the testing was carried out on hydrated samples, hydration being performed by immersing samples in 0.9% w/v saline solution at 37°C until no further net intake of water occurred (as determined by weighing samples after various time periods).
- Fig. 1 Complete stress-strain curves are shown in Fig. 1 for hydrated samples A and B (as indicated by the corresponding letters). In some cases more than one of each type of sample was prepared and therefore more than one stress-strain curve is shown.
- Fig. 2 the upper parts of the stress-strain curves are shown and it can be seen that at higher loads the traces become more linear. Because of the variability of the initial parts of the curves due to the uneven samples, compression modulus values were obtained •by taking the gradient of the curves at higher loads (between 20-30 kPa) and then were found to give more reproducible results. Moduli calculated from Fig. 2 are summarised in Table 1.
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Prostheses, e.g. disc nucleus prostheses comprising a resiliently deformable material are reinforced with physically discrete structures to form a composite. The resiliently deformable material may be a hydrophilic polymer such as a hydrogel.
Description
PROSTHETIC DEVICES
The present invention relates to prosthetic devices and in particular to such devices which deform when in use (e.g. when under compressive load).
One type of prosthesis is disclosed in US Patent No. 5047055 and comprises a hydrogel material in a shape which generally conforms to the intervertebral disc nucleus pulposes. When hydrated the hydrogel comprises a certain amount of free water which can leave the prosthesis when the disc is partially dehydrated or under mechanical pressure.
Another type of intervertebral disc nucleus prosthesis is disclosed in US Patent No. 5192326. The prosthesis comprises a multiplicity of hydrogel beads. The beads are covered by an external, semi-permeable membrane, which functions to retain the beads, but which permits fluids to flow in and out of the prosthetic nucleus.
The hydrogel materials employed in these prior devices have a tendency to become weaker and less able to withstand compressive loading as they become more fully hydrated. This may lead to failure of the prosthesis by fragmentation of the prosthesis material.
The present invention seeks to reduce the risk of stress failure of said prostheses to reduce the risk of fragmentation which may lead to adverse reactions in a host.
According to the present invention there is provided a prosthesis comprising a composite of a synthetic resiliently
deformable material having at least partially embedded therein a physically discrete reinforcing structure.
In addition to ameliorating disadvantages with prior art devices a further advantage of the prosthesis of the present invention is that it allows a wider range of resiliently deformable materials to be utilised than was hitherto the case. This is because the reinforcing structure can substantially contribute to the physical strength of the device, thereby allowing weaker deformable materials to be used than is the case with non reinforced prostheses.
The prosthesis of the present invention is suitable for replacing body components which are subject to repeated and variable compressive loads and may be shaped so as to correspond to suitable body components. For example it may be used to replace the nucleus pulposus of the intervertebral disc, the intervertebral disc in its entirety, as a replacement for the articular cartilage in joints, in place of orthopaedic bearing surfaces (eg to replace polyethylene bearing surfaces), in total joint replacement implants such as the hip, knee, shoulder, wrist, ankle, fingers and toes, as a spacer to replace segments of bone or the bone in its entirety, as a space filling implant replacing soft tissue for orthopaedic, maxillo-facial, or plastic or reconstructive surgical applications - such as to replace or augment deficiencies in bone, cartilage or soft tissue.
Preferably however the prosthesis is adapted to replace part or all of an intervertebral disc of a mammal, e.g. a human, and is shaped accordingly. Most preferably the prosthesis is adapted to replace an intervertebral disc nucleus and it therefore desirably has
a shape generally corresponding to that of a natural disc nucleus. Alternatively it may comprise a plurality of sections which are adapted, when fitted together to approximate the shape of the natural disc nucleus. For example, the nucleus may be in two halves to allow easy manipulation and to facilitate minimally invasive surgical techniques.
The reinforcing structure can be located partially or totally within the resiliently deformable material and is formed of a material which is physically discrete from said resiliently deformable material (although the reinforcing structure may itself be resiliently deformable). It is thus distinguished from systems in which polymers forming the resiliently deformable material are simply cross-linked. The material comprising the reinforcing structure may also be chemically distinct from that of the resilient material.
The reinforcing structure may function by providing a restraining means within the deformable material which reduces the tendency of the latter to shear or otherwise fail when under compressive load.
Desirably, the resiliently deformable material is in solid or semi-solid form. It may be an elastomeric polymer. Preferably it is hydrogel or a hydrophilic polymer.
Suitable hydrogels include PVA hydrogels, such as those disclosed in US-A-5192326.
Other suitable materials for the production of hydrogels or hydrophilic polymers include:
1. Acrylates:- eg acrylic acid, methacrylic acid, 2-hydroxyethyl
methacrylate, and copolymers thereof with N-vinyl pyrrolidone, N- vinyl lactams, acylamide, polyurethanes, polyacrylonitrile; copolymers of N-vinyl pyrrolidone and glycidyl acrylate, copolymers of polyethylene, polytetrafluoroethylene or polypropylene with acrylic acid, block copolymers of poly (2-hydroxyethyl methacrylate) with polystyrene, or poly (dimethyl-siloxane), para-hydroxyperfluoro-alkyl styrene, or trifluoroethyl methacrylate;
2. Acrylamides:- eg acrylamide, methacrylamide and copolymers of acrylamides such as poiyacrylamide-agarose gels, siloxy-acryiamides;
3. Silicones:- eg 1 ,3-bis-methacryloxy-propyl-1 ,1 ,3,3-tetrakis (trimethyl-siloxy) disiloxane, tris (trimethyl-siloxy) silyl-propyl methacrylate, siioxane monomers, polysiloxane-polyoxyalkylene macromers, silicone rubbers, hexamethyl disiloxane, triethoxyvinyl silane, hexamethyl disilazane;
4. Collagen:- eg copolymers with poly (2-hydroxyethyl-acrylate) or poly (vinyl alcohol);
5. Vinyl compounds:- eg N-vinyl pyrrolidone, N-vinyl lactams, hydroxyethyl cellulose vinyl and vinylic monomer, polymers of vinyl carbonate or vinyl carbamate, vinyl trifluro acetate;
6. Polyurethanes:- eg polyether, or short chain polyester based polyurethanes.
7. Naturally occurring materials (or chemically modified variants thereof):- eg glucomannan gel, hyaluronic acid, proteins, poiysaccharides or polypeptides combined with a polymer of a
hydrophilic acrylic or methacryiic acid derivative, crosslinked carboxyl containing polysaccharides, carboxymethyl cellulose, gelatin, aiginates.
Preferred hydrogels have a water content of at least 30%
(w/w) when fully hydrated at 37°C, more preferably of from 75 to 99%(w/w).
Other elastomeric polymers which may be suitable for use in the present invention include:- silicone and fluorosilicone elastomers, phosphazene elastomers, vinylidine fluoride based fluoroelastomers, natural and artificial rubbers, etc.
The prosthesis of the invention aptly has a compressive strength of at least 1 MNrrr2 at 37°C and at atmospheric pressure.
Suitable reinforcing structures include:- nets; foams; knitted, braided, crocheted, woven, or non-woven fabrics; arrays of spaced reinforcing elements; particulate filler materials; loose fibres.
The term "net" includes perforate films as well as fibrous networks. Suitable nets include those formed of nylon™, dacron™, carbon fibre etc.
The foams may be open cell foams, closed cell foams, skeletal foams, non-skeletal foams, etc. Foams which are already used in wound-dressings for example those polyurethane foams employed in wound dressings such as ALLEVYN™ foam, which is sold by Smith & Nephew Medical Ltd, Hull, UK may be particularly suitable.
The fabrics used for reinforcing structures are aptly arranged as composite structures having desirably first and second spaced apart sheets whose opposed surfaces are maintained in a spaced apart relationship by a plurality of supporting members. The first and second spaced apart surfaces may be generally parallel to one another (when the fabric is not compressed). They may be generally planar or may present corrugated surfaces. Such fabrics are often formed by warp knitting using Raschel warp knitting machinery (as described eg in USPN 4601940 and EP-A-0529671). Certain type of fabrics of this are sometimes referred to as "spacer fabric" and have been used in seating in the automotive industry. Such fabrics can be obtained from Messrs. Nippon Mayer Co. Ltd. of J-910 Fukui City, Japan; Mϋller Textile GmbH of D-51674 Wiehl- Drabenderhδhe, Germany; or Karl Mayer Textilmaschienen fabrik of D-63160 Obertshaϋsen, Germany.
The surfaces of these composite structures may be maintained in the spaced apart relationship by, for example, columns of elastomeric material or by a plurality of fibrous members arranged, for example to form a web. Such webs may be formed from non-woven fabrics.
The particulate filler material may employed is the reinforcing structure may be quartz, silica, gypsum, titanium dioxide, glass based fillers, clay-based fillers, or calcium carbonate. Filler materials are described in detail in the "Handbook of Fillers for Plastics" by Katz and Mikwski [1987], published by Van Nostrand Reinhold.
In certain cases the resiliently deformable material may be contained within an outer cover, which is desirably flexible.
Aptly the outer cover is suitably non-permeable to body fluids.
Alternatively, the outer cover may be provided to simply serve to assist in maintaining integrity or strength of the prosthesis. The outer cover may therefore be permeable to body fluids but prevent the resiliently deformable material and the reinforcing structure from passing through it. Aptly such outer covers will be in the form of a membrane or mesh. Various outer covers are disclosed in US-A- 5192326.
In the case of a replacement intervertebral disc, it may be desired to provide a prosthesis with additional means to externally reinforce and/or anchor the device.
This may take the form of a collar surrounding the prosthesis to constrain its lateral deflection. This collar may be of metal, polymeric, ceramic or composite construction and would surround the prosthesis circumferentially. This collar may be made of implantable metals such as stainless steel, cobalt chrome alloy, titanium alloy or ceramic materials such as alumina or zirconia, or composite materials such as carbon fibre reinforced PEEK, or polymers such as polyethylene. Alternatively the prosthesis may be bonded to plates of metal, ceramic, polymer or composite construction which are interspersed between the prosthesis and the bone of the vertebral bodies in cephalad and caudad directions to facilitate anchorage to the bone.
Once the prosthesis of the present invention has been formed it is necessary to introduce it into a host. This can be done by any appropriate surgical technique, but minimally invasive techniques are preferred where possible.
In order to introduce a prosthesis consisting of an inter¬ vertebral disc nucleus prosthesis into the human body this may be done from the dorsal direction by dissecting away skin, soft tissue and muscle exposing the dorsal aspect of the spinal column. A laminectomy or other surgical procedure may be performed to remove the dorsal bony elements from the column to expose the disc. The disc nucleus prosthesis is then placed in position through a surgical defect created in the posterior surface of the annulus fibrosis.
Alternatively the spinal column may be approached from the dorsal-lateral direction without removing the dorsal bony elements, again introducing the disc nucleus prosthesis through a defect created surgically in the annulus fibrosis. As a further alternative, an ventral approach to the spinal column may be used entering the body through the peritoneum or thorax to expose the ventral surface of the spinal column. The disc nucleus prosthesis would then be introduced through a defect created surgically in the anterior surface of the annulus fibrosis.
In each of these cases it is anticipated that the effected disc level would be distracted using standard surgical instruments to increase the height of the damaged disc to allow insertion of the disc nucleus prosthesis. Any of these surgical approaches may be made using a minimally invasive surgery technique such as arthroscopy, endoscopy or laparoscopy to approach the spinal column. In this case the disc nucleus prosthesis would be introduced through a defect created surgically in the annulus fibrosis through a cannula using a percutaneous approach.
The prosthesis may be dehydrated to reduce the volume of the prosthesis prior to insertion. The disc would then either be rehydrated in situ after implantation or be permitted to absorb water from the surrounding tissues during the post-operative period. This technique is particularly suitable for hydrogel prostheses.
A complete intervertebral disc prosthesis could be introduced into the human body using any of the techniques described above, with the modification that the entire disc annulus fibrosis and nucleus pulposus or a substantial portion thereof would be removed using standard surgical procedures exposing the vertebral bones, cephalad and caudad to the disc space, and the prosthesis inserted to replace the entire disc. A prosthesis could be anchored using any of the means described previously.
The following examples, which are not to be construed as limiting, illustrate ways in which articles can be formed from resiliently deformable material and reinforced with reinforcing structures. For convenience the examples illustrate the production of generally cylindrical articles. In practice however these techniques would be used to produce a prosthesis, or a component thereof, shaped as desired.
Example 1 - Synthesis of polyurethane structures reinforced with nets
The following reagents were stirred together at 60°C until a homogenous composition was obtained:-
86.3g of ethanediol
565.7g of freshly dried polyethylene glycol PEG 1500
447.9g of Desmodur W (Trade Mark for a 4,4 -
Dicyclohexyimethane di-isocyanate (obtainable from
Bayer UK Limited).
2.2g of Metatin 812ES catalyst (Trade Mark for a dioctyltin dilaurate catalyst obtainable from Cima Chemical Industries) was then added with vigorous stirring until exotherm commenced, after which the mixture was poured onto a polypropylene tray then covered with PTFE sheet and placed in an oven to cure at 90°C for 2 hours to produce a hydrophilic polyurethane, which is referred to herein as "HPU 45"
The cured HPU 45 was then broken into small pieces and dissolved by adding 15 parts by weight of tetrahydrofuran to 85 parts by weight of HPU 45.
The resultant liquid was poured into shallow trays and left to evaporate solvent slowly in a fume cupboard over 19 hours. The samples were dried in an oven at 40°C for 4 hours then in a vacuum oven at 40°C for 3 hours. The resultant films were removed from the trays, turned over and the trays replaced in the vacuum oven for a final 5.5 hours.
Equally sized discs of diameter 14mm and thickness 1mm were then cut out of the films. From a polyalkylene net obtainable from Smith & Nephew Extruded Films Ltd. of Gilberdyke, UK under the designation of "Net 909 (Grade L40)" further discs of diameter 14mm were cut. The thickness of these discs was 0.15mm and the nets weighed 13.6 g/m2.
Different arrangements were produced as follows:-
Sample A - Stack consists of two HPU 45 discs, then one net disc, then two HPU 45 discs, then one net disc, then two HPU 45 discs.
Sample B (control) - Stack consists of six HPU 45 discs.
Once the stacks were formed the discs were laminated together by heating in an oven at 100°C for 10 mins with a 15g weight being placed on the top of each stack.
After removal from the oven, the laminated stacks were allowed to cool to room temperature.
Example 2 - Synthesis of a poly Hydroxyethylmethacrylate hvdroαel reinforced with a knitted fabric.
A stock solution was prepared by adding azoisobutylnitrile to hydroxyethylmethacrylate (HEMA) at a level of 0.15% w/w. The solution was then de-aerated by bubbling with nitrogen for 15 mins.
A mould was obtained for producing moulded discs shaped articles of diameter 14mm and depth 9mm. The solution was powered into the mould to a depth of about 2mm and a disc cut out of a knitted "spacer fabric" to have a diameter of 14mm was placed above the HEMA (once it had thickened sufficiently to support the disc). The knitted fabric was obtainable from under the designation of Karl Meyer Textelmaschinen Fabrik of D.63160 Obertshausen, Germany and consists of two planer surfaces interconnected by monofilaments. Each planar surface is knitted to provide a "honeycomb" structure of interconnecting hexagons. It has a thickness of about 5mm.
The solution was then poured over the knitted fabric a until the mould was full and the mould was then sealed and put in a water bath (containing a tablespoon of sodium metabisulphite) at 50°C for 3 hours. The temperature was then increased to 80°C for 2 hours and then reduced to 60°C for 17 hours. The mould was finally put in an oven at 100°C for 24 hours to anneal.
After cooling at room temperature for several hours the mould was opened and the moulded article, referred to as sample C, was removed.
A control sample, sample D, was also prepared, using a corresponding procedure to that described above except that no knitted fabric was used (ie sample D consisted of poly HEMA only).
A further control sample, sample E, was prepared, consisting of a sample of the knitted fabric only, cut to the same size as the moulded samples.
Physical Testing of Samples
Static compression testing was carried out on samples prepared according to Examples 1 and 2 using a Rheometrics Solid Analyser RSA II, available from Rheometrics (UK), Englefield Green, Surrey, UK. In the tests strain was increased in steps of 0.2% up to approximately 30%.
The testing was carried out on hydrated samples, hydration being performed by immersing samples in 0.9% w/v saline solution
at 37°C until no further net intake of water occurred (as determined by weighing samples after various time periods).
Complete stress-strain curves are shown in Fig. 1 for hydrated samples A and B (as indicated by the corresponding letters). In some cases more than one of each type of sample was prepared and therefore more than one stress-strain curve is shown.
The results are variable and most samples showed an initially low gradient which increases with increasing load. This is probabiy due to the fact that some samples were uneven and the top and bottom surfaces were not perfectly parallel.
In Fig. 2 the upper parts of the stress-strain curves are shown and it can be seen that at higher loads the traces become more linear. Because of the variability of the initial parts of the curves due to the uneven samples, compression modulus values were obtained •by taking the gradient of the curves at higher loads (between 20-30 kPa) and then were found to give more reproducible results. Moduli calculated from Fig. 2 are summarised in Table 1.
Table 1
Hydrated Sample Modulus/kPa Mean Modulus/kPa
B 236 234
233
A 280
280 284
293
The results show an average increase of over 20% in stiffness for the samples with 2 layers of net compared to samples with
HPU45 alone.
The same testing procedure described above was performed upon samples C, D and E and the results are shown in Figs. 3 and 4. Gradients were calculated at high loads (20-30 kPa) and the results are illustrated in Table 2 below.
Table 2
Sample Modulus/kPa Mean Modulus/kPa
D 644 643
625
660
C 923 863
855
E 424 424
The results show an average increase in stiffness of over 30% for the poly HEMA samples reinforced with the knitted fabrics relative to poly HEMA alone.
Claims
1. A prosthesis comprising a composite of a synthetic resiliently deformable matrix material having at least partially embedded therein a physically discrete reinforcing structure.
2. A prosthesis as claimed in claim 1 having a compression strength of at least 1MNm"2 (at 37°C and atmospheric pressure).
3. A prosthesis as claimed in claim 1 or claim 2 wherein the resiliently deformable material is a hydrophilic polymer.
4. A prosthesis as claimed in claim 3 where the hydrophilic polymer is a hydrogel.
5. A prosthesis as claimed in claim 4 wherein the hydrogel has a water content of at least 30% (w/w) when fully hydrated at 37°C.
6. A prosthesis as claimed in any one of the preceding claims wherein the reinforcing structure comprises one or more materials chemically distinct from that of the resiliently deformable material.
7. A prosthesis as claimed in any one of the preceding claims wherein the reinforcing structure comprises a net, a foam, knitted, woven or non-woven fabrics.
8. A prosthesis as claimed in claim 7 wherein the reinforcing structure comprise at least one pair of sheets maintained in spaced apart relationship by a plurality of supporting members.
9. A prosthesis as claimed in claim 8 wherein the supporting members are physically defined by fibrous web.
10. A prosthesis as claimed in any one of the preceding claims wherein the resiliently deformable material is at least partially enveloped by and contained within a cover.
11. A prosthesis as claimed in claim 10 wherein the cover is non- permeable to body fluids.
12. A prosthesis as claimed in claim 10 or claim 11 wherein the cover forms part of the reinforcing structure.
13. A prosthesis as claimed in claim 10 or claim 11 wherein said sheets as defined in claim 8 comprise the cover.
14. A prosthesis as claimed in any one of the preceding claims further provided with additional wholly external support means.
15. A disc nucleus prosthesis as defined in any one of the preceding claims.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28020/95A AU2802095A (en) | 1994-07-08 | 1995-07-03 | Prosthetic devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9413855.9 | 1994-07-08 | ||
GB9413855A GB9413855D0 (en) | 1994-07-08 | 1994-07-08 | Prosthetic devices |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996001598A1 true WO1996001598A1 (en) | 1996-01-25 |
Family
ID=10758068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1995/001550 WO1996001598A1 (en) | 1994-07-08 | 1995-07-03 | Prosthetic devices |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2802095A (en) |
GB (1) | GB9413855D0 (en) |
WO (1) | WO1996001598A1 (en) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2787018A1 (en) * | 1998-12-11 | 2000-06-16 | Dimso Sa | INTERVERTEBRAL DISC PROSTHESIS WITH LIQUID ENCLOSURE |
WO2002038197A3 (en) * | 2000-11-09 | 2002-10-10 | Polymer Technology Group Inc | Devices that change size/shape via osmotic pressure |
WO2002085262A1 (en) * | 2001-04-24 | 2002-10-31 | Galley Geoffrey H | Surgical restoration of an intervertebral disc |
US6620196B1 (en) | 2000-08-30 | 2003-09-16 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US6733532B1 (en) | 1998-12-11 | 2004-05-11 | Stryker Spine | Intervertebral disc prosthesis with improved mechanical behavior |
US6733531B1 (en) | 2000-10-20 | 2004-05-11 | Sdgi Holdings, Inc. | Anchoring devices and implants for intervertebral disc augmentation |
US6974479B2 (en) | 2002-12-10 | 2005-12-13 | Sdgi Holdings, Inc. | System and method for blocking and/or retaining a prosthetic spinal implant |
US7001433B2 (en) | 2002-05-23 | 2006-02-21 | Pioneer Laboratories, Inc. | Artificial intervertebral disc device |
US7066960B1 (en) * | 2002-06-28 | 2006-06-27 | Dickman Curtis A | Intervertebral disk replacement |
US7204851B2 (en) | 2000-08-30 | 2007-04-17 | Sdgi Holdings, Inc. | Method and apparatus for delivering an intervertebral disc implant |
US7204897B2 (en) * | 1999-09-30 | 2007-04-17 | Replication Medical, Inc. | Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc |
US7297146B2 (en) | 2004-01-30 | 2007-11-20 | Warsaw Orthopedic, Inc. | Orthopedic distraction implants and techniques |
US7500978B2 (en) | 2003-06-20 | 2009-03-10 | Intrinsic Therapeutics, Inc. | Method for delivering and positioning implants in the intervertebral disc environment |
US7503936B2 (en) | 2000-08-30 | 2009-03-17 | Warsaw Orthopedic, Inc. | Methods for forming and retaining intervertebral disc implants |
US7507243B2 (en) | 1999-08-18 | 2009-03-24 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
US7513911B2 (en) | 1999-08-18 | 2009-04-07 | Intrinsic Therapeutics, Inc. | Method of implanting dynamically stable spinal implant |
US7524333B2 (en) | 1999-08-18 | 2009-04-28 | Intrinsic Therapeutics, Inc. | Method of anchoring an implant in an intervertebral disc |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US7618461B2 (en) | 2000-08-30 | 2009-11-17 | Warsaw Orthopedic, Inc. | Composite intervertebral disc implants and methods for forming the same |
US8012187B2 (en) | 2002-08-14 | 2011-09-06 | Warsaw Orthopedic, Inc. | Techniques for spinal surgery and attaching constructs to vertebral elements |
US8066750B2 (en) | 2006-10-06 | 2011-11-29 | Warsaw Orthopedic, Inc | Port structures for non-rigid bone plates |
US8663225B2 (en) | 2004-11-12 | 2014-03-04 | Medtronic, Inc. | Hydrogel bone void filler |
US9039741B2 (en) | 2005-12-28 | 2015-05-26 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
US9226832B2 (en) | 2007-09-07 | 2016-01-05 | Intrinsic Therapeutics, Inc. | Interbody fusion material retention methods |
US9233011B2 (en) | 2006-09-15 | 2016-01-12 | Pioneer Surgical Technology, Inc. | Systems and apparatuses for inserting an implant in intervertebral space |
US9241807B2 (en) | 2011-12-23 | 2016-01-26 | Pioneer Surgical Technology, Inc. | Systems and methods for inserting a spinal device |
US9351852B2 (en) | 2002-05-23 | 2016-05-31 | Pioneer Surgical Technology, Inc. | Artificial disc device |
US9445916B2 (en) | 2003-10-22 | 2016-09-20 | Pioneer Surgical Technology, Inc. | Joint arthroplasty devices having articulating members |
US9706947B2 (en) | 1999-08-18 | 2017-07-18 | Intrinsic Therapeutics, Inc. | Method of performing an anchor implantation procedure within a disc |
USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
US11147682B2 (en) | 2017-09-08 | 2021-10-19 | Pioneer Surgical Technology, Inc. | Intervertebral implants, instruments, and methods |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867728A (en) * | 1971-12-30 | 1975-02-25 | Cutter Lab | Prosthesis for spinal repair |
EP0346129A1 (en) * | 1988-06-10 | 1989-12-13 | University Of Medicine And Dentistry Of New Jersey | Functional and biocompatible intervertebral disc spacer |
EP0372811A1 (en) * | 1988-12-02 | 1990-06-13 | Stryker Corporation | Implant |
US5047055A (en) * | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
-
1994
- 1994-07-08 GB GB9413855A patent/GB9413855D0/en active Pending
-
1995
- 1995-07-03 AU AU28020/95A patent/AU2802095A/en not_active Abandoned
- 1995-07-03 WO PCT/GB1995/001550 patent/WO1996001598A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867728A (en) * | 1971-12-30 | 1975-02-25 | Cutter Lab | Prosthesis for spinal repair |
EP0346129A1 (en) * | 1988-06-10 | 1989-12-13 | University Of Medicine And Dentistry Of New Jersey | Functional and biocompatible intervertebral disc spacer |
EP0372811A1 (en) * | 1988-12-02 | 1990-06-13 | Stryker Corporation | Implant |
US5047055A (en) * | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU765060B2 (en) * | 1998-12-11 | 2003-09-04 | Stryker Spine | Intervertebral disc prosthesis with liquid chamber |
WO2000035386A1 (en) * | 1998-12-11 | 2000-06-22 | Dimso (Distribution Medicale Du Sud-Ouest) | Intervertebral disc prosthesis with liquid chamber |
US6395032B1 (en) | 1998-12-11 | 2002-05-28 | Dimso (Distribution Medicale Du Sud-Ouest) | Intervertebral disc prosthesis with liquid chamber |
FR2787018A1 (en) * | 1998-12-11 | 2000-06-16 | Dimso Sa | INTERVERTEBRAL DISC PROSTHESIS WITH LIQUID ENCLOSURE |
US6733532B1 (en) | 1998-12-11 | 2004-05-11 | Stryker Spine | Intervertebral disc prosthesis with improved mechanical behavior |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US7524333B2 (en) | 1999-08-18 | 2009-04-28 | Intrinsic Therapeutics, Inc. | Method of anchoring an implant in an intervertebral disc |
US7553330B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an intervertebral disc annulus |
US7513911B2 (en) | 1999-08-18 | 2009-04-07 | Intrinsic Therapeutics, Inc. | Method of implanting dynamically stable spinal implant |
US7507243B2 (en) | 1999-08-18 | 2009-03-24 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
US9706947B2 (en) | 1999-08-18 | 2017-07-18 | Intrinsic Therapeutics, Inc. | Method of performing an anchor implantation procedure within a disc |
US9333087B2 (en) | 1999-08-18 | 2016-05-10 | Intrinsic Therapeutics, Inc. | Herniated disc repair |
US7204897B2 (en) * | 1999-09-30 | 2007-04-17 | Replication Medical, Inc. | Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc |
US6620196B1 (en) | 2000-08-30 | 2003-09-16 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US7503936B2 (en) | 2000-08-30 | 2009-03-17 | Warsaw Orthopedic, Inc. | Methods for forming and retaining intervertebral disc implants |
US7618461B2 (en) | 2000-08-30 | 2009-11-17 | Warsaw Orthopedic, Inc. | Composite intervertebral disc implants and methods for forming the same |
US7204851B2 (en) | 2000-08-30 | 2007-04-17 | Sdgi Holdings, Inc. | Method and apparatus for delivering an intervertebral disc implant |
US6893466B2 (en) | 2000-08-30 | 2005-05-17 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US6733531B1 (en) | 2000-10-20 | 2004-05-11 | Sdgi Holdings, Inc. | Anchoring devices and implants for intervertebral disc augmentation |
US7368056B2 (en) | 2000-11-09 | 2008-05-06 | The Polymer Technology Group, Incorporated | Production of potable liquids |
US6692528B2 (en) | 2000-11-09 | 2004-02-17 | The Polymer Technology Group Incorporated | Devices that change size/shape via osmotic pressure |
WO2002038197A3 (en) * | 2000-11-09 | 2002-10-10 | Polymer Technology Group Inc | Devices that change size/shape via osmotic pressure |
WO2002085262A1 (en) * | 2001-04-24 | 2002-10-31 | Galley Geoffrey H | Surgical restoration of an intervertebral disc |
US7001433B2 (en) | 2002-05-23 | 2006-02-21 | Pioneer Laboratories, Inc. | Artificial intervertebral disc device |
US9351852B2 (en) | 2002-05-23 | 2016-05-31 | Pioneer Surgical Technology, Inc. | Artificial disc device |
US8262731B2 (en) | 2002-05-23 | 2012-09-11 | Pioneer Surgical Technology, Inc. | Artificial disc device |
US7066960B1 (en) * | 2002-06-28 | 2006-06-27 | Dickman Curtis A | Intervertebral disk replacement |
US8012187B2 (en) | 2002-08-14 | 2011-09-06 | Warsaw Orthopedic, Inc. | Techniques for spinal surgery and attaching constructs to vertebral elements |
US6974479B2 (en) | 2002-12-10 | 2005-12-13 | Sdgi Holdings, Inc. | System and method for blocking and/or retaining a prosthetic spinal implant |
US7500978B2 (en) | 2003-06-20 | 2009-03-10 | Intrinsic Therapeutics, Inc. | Method for delivering and positioning implants in the intervertebral disc environment |
US9445916B2 (en) | 2003-10-22 | 2016-09-20 | Pioneer Surgical Technology, Inc. | Joint arthroplasty devices having articulating members |
US7297146B2 (en) | 2004-01-30 | 2007-11-20 | Warsaw Orthopedic, Inc. | Orthopedic distraction implants and techniques |
US8142476B2 (en) | 2004-01-30 | 2012-03-27 | Warsaw Orthopedic, Inc. | Orthopedic distraction implants and techniques |
US8663225B2 (en) | 2004-11-12 | 2014-03-04 | Medtronic, Inc. | Hydrogel bone void filler |
US9610106B2 (en) | 2005-12-28 | 2017-04-04 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
US9039741B2 (en) | 2005-12-28 | 2015-05-26 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
US11185354B2 (en) | 2005-12-28 | 2021-11-30 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
US10470804B2 (en) | 2005-12-28 | 2019-11-12 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
US9233011B2 (en) | 2006-09-15 | 2016-01-12 | Pioneer Surgical Technology, Inc. | Systems and apparatuses for inserting an implant in intervertebral space |
US9693872B2 (en) | 2006-09-15 | 2017-07-04 | Pioneer Surgical Technology, Inc. | Intervertebral disc implant |
US10080667B2 (en) | 2006-09-15 | 2018-09-25 | Pioneer Surgical Technology, Inc. | Intervertebral disc implant |
US8066750B2 (en) | 2006-10-06 | 2011-11-29 | Warsaw Orthopedic, Inc | Port structures for non-rigid bone plates |
US10716685B2 (en) | 2007-09-07 | 2020-07-21 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems |
US9226832B2 (en) | 2007-09-07 | 2016-01-05 | Intrinsic Therapeutics, Inc. | Interbody fusion material retention methods |
US10076424B2 (en) | 2007-09-07 | 2018-09-18 | Intrinsic Therapeutics, Inc. | Impaction systems |
US9241807B2 (en) | 2011-12-23 | 2016-01-26 | Pioneer Surgical Technology, Inc. | Systems and methods for inserting a spinal device |
US10980575B2 (en) | 2011-12-23 | 2021-04-20 | Pioneer Surgical Technology, Inc. | Instrument for inserting a spinal device |
US10159514B2 (en) | 2011-12-23 | 2018-12-25 | Pioneer Surgical Technology, Inc. | Method of implanting a bone plate |
US11696786B2 (en) | 2011-12-23 | 2023-07-11 | Pioneer Surgical Technology, Inc. | Instrument for inserting a spinal device |
US11147682B2 (en) | 2017-09-08 | 2021-10-19 | Pioneer Surgical Technology, Inc. | Intervertebral implants, instruments, and methods |
US12279965B2 (en) | 2017-09-08 | 2025-04-22 | Xtant Medical Holdings, Inc. | Intervertebral implants, instruments, and methods |
USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
USD968613S1 (en) | 2017-10-09 | 2022-11-01 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
Also Published As
Publication number | Publication date |
---|---|
GB9413855D0 (en) | 1994-08-24 |
AU2802095A (en) | 1996-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996001598A1 (en) | Prosthetic devices | |
USRE42837E1 (en) | Spinal nucleus implant | |
US5047055A (en) | Hydrogel intervertebral disc nucleus | |
JP2735517B2 (en) | Hydrogel intervertebral disc nucleus | |
EP0563332B1 (en) | Hydrogel intervertebral disc nucleus | |
US7503936B2 (en) | Methods for forming and retaining intervertebral disc implants | |
JP3909049B2 (en) | Radiovisible hydrogel intervertebral disc nucleus | |
US6187048B1 (en) | Intervertebral disc implant | |
US6620196B1 (en) | Intervertebral disc nucleus implants and methods | |
US20020183845A1 (en) | Multi-perforated non-planar device for anchoring cartilage implants and high-gradient interfaces | |
KR100980170B1 (en) | Hydrogel-based prosthetic device for replacing at least a portion of the nucleus of spinal disc | |
JP2007504899A (en) | Flexible spine | |
AU2004322968A1 (en) | Inflatable nuclear prosthesis | |
WO2007087364A2 (en) | Methods of producing pva hydrogel implants and related devices | |
WO2006096889A2 (en) | Materials, devices, and methods for in-situ formation of composite intervertebral implants | |
AU2003205191B2 (en) | Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc | |
AU2007203293A1 (en) | Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |